KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Intangibles (2016 - 2025)

Cvs Health's Intangibles history spans 17 years, with the latest figure at $25.5 billion for Q4 2025.

  • For the quarter ending Q4 2025, Intangibles fell 6.64% year-over-year to $25.5 billion, compared with a TTM value of $25.5 billion through Dec 2025, down 6.64%, and an annual FY2025 reading of $25.5 billion, down 6.64% over the prior year.
  • Intangibles for Q4 2025 was $25.5 billion at Cvs Health, down from $26.0 billion in the prior quarter.
  • The five-year high for Intangibles was $30.6 billion in Q1 2021, with the low at $24.8 billion in Q4 2022.
  • Average Intangibles over 5 years is $27.9 billion, with a median of $28.2 billion recorded in 2022.
  • Year-over-year, Intangibles decreased 14.85% in 2022 and then increased 17.86% in 2023.
  • Tracing CVS's Intangibles over 5 years: stood at $29.0 billion in 2021, then dropped by 14.55% to $24.8 billion in 2022, then grew by 17.86% to $29.2 billion in 2023, then dropped by 6.54% to $27.3 billion in 2024, then dropped by 6.64% to $25.5 billion in 2025.
  • Per Business Quant, the three most recent readings for CVS's Intangibles are $25.5 billion (Q4 2025), $26.0 billion (Q3 2025), and $26.2 billion (Q2 2025).